Current Edition


Beyond Pill Count: Challenging the Status Quo for Medication Adherence in Clinical Trials

Poor adherence to the investigational product can bring even the most carefully planned clinical trial to its knees. It is time to accept that traditional …

Continue Reading →

FDA chides Eli Lilly for second misleading ad in 2 months, this time for diabetes blockbuster Trulicity

After neatly wrapping up concerns over a series of Emgality ads last month, Eli Lilly is back in hot water with the FDA’s Office of …

Continue Reading →

Cannabidiol shows promise alongside conventional epilepsy medication in Lennox-Gastaut Syndrome

The use of medical cannabis to treat seizures has been in the news a lot this week due to the current case involving 12-year old …

Continue Reading →

ReCor Medical Announces Completion of RADIANCE-HTN SOLO Hypertension Study

ReCor Medical announced today randomization of its 146th, and final, subject in the SOLO cohort of its RADIANCE-HTN study.  RADIANCE-HTN, ReCor’s study of its Paradise Renal …

Continue Reading →

CRF Health’s TrialMax Touch® Selected by Leading Specialty Pharmaceutical Company for Pediatric Rare Disease Phase II Study

CRF Health, the leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, has been selected by a leading specialty …

Continue Reading →